Literature DB >> 16907703

Adrenergic receptor polymorphisms associated with resting heart rate: the HyperGEN Study.

J B Wilk1, R H Myers, J S Pankow, S C Hunt, M F Leppert, B I Freedman, M A Province, R C Ellison.   

Abstract

The association between polymorphisms in the beta1, beta2 and alpha2B adrenergic receptor (ADR) genes (ADRB1, ADRB2 and ADRA2B) and resting heart rate was examined in white and African-American participants of the HyperGEN Study. All analyses were adjusted for age, sex, body mass index, alcohol use, smoking status and daily exercise within strata of race, hypertension status and beta-blocker use. The Ser49Gly polymorphism of the beta1 ADR was associated with resting heart rate in hypertensive African-Americans and hypertensive whites taking beta-blockers, with carriers of the Gly allele having a higher mean resting heart rate by 2.7 and 4.4 beats per minute (bpm), respectively. The Arg389Gly polymorphism of the beta1 ADR was associated with lower heart rate in the normotensive African-American sample. A beta1 haplotype (Ser49Gly-Arg389Gly) was modestly associated with resting heart rate in the hypertensive African-Americans. The alpha2B C/A polymorphism was associated with heart rate in hypertensive whites, and both whites and African-Americans taking beta-blockers, with carriers of the A allele having a higher mean resting heart rate. In summary, each of the ADR gene polymorphisms was associated with heart rate in at least one stratum studied, but there was no consistent association from which one would infer a large genetic contribution to heart rate.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16907703     DOI: 10.1111/j.1469-1809.2005.00258.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  15 in total

1.  Genome-wide association analysis identifies multiple loci related to resting heart rate.

Authors:  Mark Eijgelsheim; Christopher Newton-Cheh; Nona Sotoodehnia; Paul I W de Bakker; Martina Müller; Alanna C Morrison; Albert V Smith; Aaron Isaacs; Serena Sanna; Marcus Dörr; Pau Navarro; Christian Fuchsberger; Ilja M Nolte; Eco J C de Geus; Karol Estrada; Shih-Jen Hwang; Joshua C Bis; Ina-Maria Rückert; Alvaro Alonso; Lenore J Launer; Jouke Jan Hottenga; Fernando Rivadeneira; Peter A Noseworthy; Kenneth M Rice; Siegfried Perz; Dan E Arking; Tim D Spector; Jan A Kors; Yurii S Aulchenko; Kirill V Tarasov; Georg Homuth; Sarah H Wild; Fabio Marroni; Christian Gieger; Carmilla M Licht; Ronald J Prineas; Albert Hofman; Jerome I Rotter; Andrew A Hicks; Florian Ernst; Samer S Najjar; Alan F Wright; Annette Peters; Ervin R Fox; Ben A Oostra; Heyo K Kroemer; David Couper; Henry Völzke; Harry Campbell; Thomas Meitinger; Manuela Uda; Jacqueline C M Witteman; Bruce M Psaty; H-Erich Wichmann; Tamara B Harris; Stefan Kääb; David S Siscovick; Yalda Jamshidi; André G Uitterlinden; Aaron R Folsom; Martin G Larson; James F Wilson; Brenda W Penninx; Harold Snieder; Peter P Pramstaller; Cornelia M van Duijn; Edward G Lakatta; Stephan B Felix; Vilmundur Gudnason; Arne Pfeufer; Susan R Heckbert; Bruno H Ch Stricker; Eric Boerwinkle; Christopher J O'Donnell
Journal:  Hum Mol Genet       Date:  2010-07-16       Impact factor: 6.150

2.  Heritability and linkage study on heart rates in a Mongolian population.

Authors:  Bayasgalan Gombojav; Hansoo Park; Jong Il Kim; Young Seok Ju; Joohon Sung; Sung Il Cho; Mi Kyeong Lee; Heechoul Ohrr; Janchiv Radnaabazar; Jeong Sun Seo
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

Review 3.  Genomics of Cardiovascular Measures of Autonomic Tone.

Authors:  Martin I Sigurdsson; Nathan H Waldron; Andrey V Bortsov; Shad B Smith; William Maixner
Journal:  J Cardiovasc Pharmacol       Date:  2018-03       Impact factor: 3.105

4.  β-1 and β-2 adrenergic receptor polymorphism and association with cardiovascular response to orthostatic screening.

Authors:  E D Wittwer; Z Liu; N D Warner; D R Schroeder; A M Nadeau; A R Allen; C J Murillo; R L Elvebak; B M Aakre; J H Eisenach
Journal:  Auton Neurosci       Date:  2011-07-31       Impact factor: 3.145

5.  ADRB1 variants in atrial fibrillation: small steps and giant leaps toward personalized therapy in cardiovascular disease.

Authors:  Sharon Cresci
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

6.  Pharmacogenetic Associations of β1-Adrenergic Receptor Polymorphisms With Cardiovascular Outcomes in the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).

Authors:  Oyunbileg Magvanjav; Caitrin W McDonough; Yan Gong; Leslie A McClure; Robert L Talbert; Richard B Horenstein; Alan R Shuldiner; Oscar R Benavente; Braxton D Mitchell; Julie A Johnson
Journal:  Stroke       Date:  2017-03-28       Impact factor: 7.914

7.  β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysis.

Authors:  Hao Wang; Jielin Liu; Kuo Liu; Ya Liu; Zuoguang Wang; Yuqing Lou; Qiuli Niu; Wei Gu; Lijuan Wang; Mei Li; Xiaoling Zhu; Shaojun Wen
Journal:  Mol Biol Rep       Date:  2013-04-16       Impact factor: 2.316

8.  AGT M235T genotype/anxiety interaction and gender in the HyperGEN study.

Authors:  Sarah S Knox; Xinxin Guo; Yuqing Zhang; G Weidner; Scott Williams; R Curtis Ellison
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

9.  Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade.

Authors:  Daniel Kurnik; Chun Li; Gbenga G Sofowora; Eitan A Friedman; Mordechai Muszkat; Hong-Guang Xie; Paul A Harris; Scott M Williams; Usha B Nair; Alastair J J Wood; C Michael Stein
Journal:  Pharmacogenet Genomics       Date:  2008-10       Impact factor: 2.089

10.  Human heart rate: heritability of resting and stress values in twin pairs, and influence of genetic variation in the adrenergic pathway at a microribonucleic acid (microrna) motif in the 3'-UTR of cytochrome b561 [corrected].

Authors:  Kuixing Zhang; Dekker C Deacon; Fangwen Rao; Andrew J Schork; Maple M Fung; Jill Waalen; Nicholas J Schork; Caroline M Nievergelt; Neil C Chi; Daniel T O'Connor
Journal:  J Am Coll Cardiol       Date:  2013-10-16       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.